Centuple Global Ltd
₹0.00▲ +0.00 (+0.00%)
531099·NSE·Healthcare
Market Cap
19.40 Cr
PE Ratio
12.80
Volume
—
Day High - Low
—
52W High-Low
144.40 - 28.22
₹0.00▲ +0.00 (+0.00%)
Market Cap19.40 Cr
PE Ratio12.80
Volume—
Day High - Low—
52W High-Low144.40 - 28.22
Centuple Global Ltd (531099): company summary
Centuple Global Ltd (531099) is a micro-cap Healthcare company valued at ₹19 crore operating in Pharmaceuticals on the NSE and BSE.
Centuple Global Ltd (531099) is a micro-cap Healthcare company valued at ₹19 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 731.0% a year over three years. Return on equity is 12.7%.
- Valuation multiples
- The stock trades at 12.8 times earnings, a discount to the Healthcare median of 32.5, 0.83 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.7/10
Fair
Fair Value
Sign in to see
ROE
12.70%
Average
P/E
12.80x
Cheap
Debt / Equity
0.30
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹28.22
₹144.40
DocStoX take
Supported by valuation (9.0) and growth (9.0), but held back by quality (2.3). Valuation looks strong at 9.0, but that is offset by quality at 2.3. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence5.7
/10
Fair
Quality
Weak
ROE 12.7%
Valuation
Cheap
P/E 12.8×
Growth
Strong
Revenue +731.0% 3Y CAGR
Risk
Elevated
D/E 0.30
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹19 Cr
52W High / Low
₹144 / ₹28
Dividend Yield
0.00%
Promoter Holding
0.00%
EPS (TTM)
₹0.05
Book Value
₹42.47
Key highlights
- Revenue compounding 731% a year
- Undemanding at 13× earnings
- Loss-making in some of the last 5 years
- Quality is weak (2.3/10)
2 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Centuple Global Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Centuple Global Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Centuple Global Ltd with peers
Related tools & concepts
Value Centuple Global Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing